Recent Stories at AdventHealth Research Institute
-
PeopleAnita Fletcher, MD | Appointed by NKGen as National Principal Investigator for Phase 2a Troculeucel Trial
NKGen Biotech today announced that Anita Fletcher, M.D. has been appointed as the National Principal Investigator (“PI”) for its Phase 2a clinical trial of troculeucel.
-
CareAdventHealth Research Contributed to New Method for Tracking Diet and Its Impacts on Human Health
Accurately determining food intake remains a challenge in nutrition research. A new study published in Nature Metabolism, introduces a metagenomics-powered approach to accurately track dietary intake...
-
CareAdventHealth Cancer Institute | Becker’s Hospital Review in the Top 100 Hospitals and Health Systems
The AdventHealth Cancer Institute has been recognized in Becker's Hospital Review as one of the top 100 hospitals and health systems in the country for its excellence in oncology.
-
CareAccelerating Orthopedic Innovation Through Research
In this blog Dr. Amir Kachooei shares his view on AdventHealth's orthopedic research efforts and the future of orthopedic medicine.
-
CareWassim McHayleh, MD | An Investigational Breast Cancer Drug Has Been a Game Changer for a Central FL Patient
Florida Trend for Breast Cancer Month features Dr. McHayleh and his clinical trial Tropion! A participant in the study was declared cancer-free after about 5 months of treatment.
-
PeoplePatricia Robinson, PhD | 50 Most Influential Clinical Executives - 2024 | Modern Healthcare
Dr. Patricia Robinson has received has been named one of 50 Most Influential Clinical Executives in 2024 by Modern Healthcare.
-
CareJust for kicks: Rothman Orthopaedics at AdventHealth helps U.S. Men’s National Soccer Team hit health goals during important summer events
Dr. Daryl Osbahr serves as team orthopedic surgeon and team physician for U.S. Men's National Soccer Team.
and helps the team hit health goals during summer events. -
CareRichard E. Pratley, MD | Ozempic and Wegovy Slash Kidney Disease Risks in People With Diabetes
In a recent study, health complications dropped by 24 percent in those taking semaglutide, the active ingredient in Ozempic and Wegovy.
-
CareAnna Casu, MD | The Becker's Healthcare Podcast features Dr. Casu discussing her experience with T1 diabetes.
In this episode, Dr. Anna Casu, shares her background and personal journey with Type 1 diabetes. She also provides insights into AdventHealth’s ACCESS-T1D study, emphasizing the importance of...